Dublin, June 18, 2018 (GLOBE NEWSWIRE) -- The "Immunochemicals - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Immunochemicals in US$ Thousand by the following Product Types:
- Catalog Antibodies
- Custom Antibodies
The report profiles 116 companies including many key and niche players such as:
- Abcam Plc. (UK)
- Agilent Research Laboratories (USA)
- Beckman Coulter GmbH (USA)
- Biolegend, Inc. (USA)
- Bio-Rad Laboratories, Inc. (USA)
- Cell Signaling Technology, Inc. (USA)
- GenScript Biotech Corporation
- PerkinElmer, Inc. (USA)
- Rockland Immunochemicals, Inc. (USA)
- Santa Cruz Biotechnology, Inc. (USA)
- Merck (Sigma-Aldrich Corporation) (USA)
- Thermo Fisher Scientific Inc. (USA)
Key Topics Covered:
1. INDUSTRY OVERVIEW Immunochemicals A Prelude Research Antibodies Market: Critical Role in Drug Discovery and Research Key Factors Influencing Purchasing Decisions Citations: One of the Key Factors Driving Research Antibodies' Purchase The US Dominates the Global Immunochemicals Market Emerging Markets Offer Huge Potential Catalog Antibodies The Largest Market Segment Custom Antibodies: Finding Favor in Research Applications Primary Antibodies Dominate the Market Competitive Scenario 2. MARKET TRENDS AND GROWTH DRIVERS Increasing Research Funding Bolsters Market Growth Chinese Market to Become the Largest Investor in Basic Research Cancer Research Drives the Global Immunochemicals Market Cancer Ranks Among the Top Ten Causes of Death Worldwide Reproducibility Crisis' of Antibodies A Major Cause of Concern Proper Validation of Antibodies Vendor Do their Part New Technologies for Antibodies Validation Personalized Medicine Offers New Growth Avenues Rabbit Monoclonal Antibodies Score over Other Animal Antibodies Researchers Prefer Commercial Research to Academic Research Increasing Collaborations between Industry and Academia 3. AN INTRODUCTION TO IMMUNOCHEMICALS 4. ANTIBODIES - A PRIMER Introduction to Antibodies Antibodies in Research Applications Monoclonal Antibodies Properties Applications Monoclonal Antibodies for Cancer Treatment Various Types of mAbs Used in Cancer Treatment Polyclonal Antibodies Production Process Properties Applications Conjugate Antibodies Antibody Drug Conjugate Technology An Overview ADC Technology Its Evolution and Developmental Challenges Antibody Technology Enables Better Specificity and Batch Consistency (2016) ABfinity Technology Linker Technology Challenges Pre-requisites of an Effective ADC ADC Manufacturing The Need for Outsourcing Target Antigen Selection Critical in Developing Successful ADCs Forms of Tumor-Related Antigens Availability of ADCs Antibody-Drug Conjugates (ADCs) in Development ADC Market: An Insight into the Future 5. RECENT INDUSTRY ACTIVITY MedImmune & Sanofi Pasteur Enters Agreement to Develop & Commercialize MEDI8897 TRIANNI Signs License Agreement with Fred Hutch ImmunoPrecise Introduces New Research Initiative Green Mountain Signs Agreement with ILRI Abcam Extends License & Supply Agreement with Horizon Discovery Shire Plc. Signs License Agreement with Novimmune S.A to Broaden Monoclonal Antibody Research Platform Morphotek Partners with Johns Hopkins University to Research and Develop of Biological Therapies Rockland Announces Availability of New Melanoma Cell Lines for Research Kymab and MD Anderson Team Up for R&D in Immuno-Oncology Achaogen and Crystal Bioscience to Develop Multiple Targeted Antibodies Zymeworks Announces the Merger and Acquisition of Kairos Therapeutics Merck Acquires Sigma-Aldrich Abzena Acquires The Chemistry Research Solution LLC Abcam Enters into a Definitive Agreement to Acquire AxioMx. Igenica Biotherapeutics Signs Deal with MedImmune Regeneron Pharma Signs Deal with The Experimental Therapeutics Institute Invenra Partners with Oxford BioTherapeutics Bio-Rad Labs Releases PrecisonAb Antibodies for use in Western Blotting Cell Signaling Technology Releases 6 New Monoclonal Antibodies Abcam Launches an Anti-PD-L1 Primary Antibody 6. FOCUS ON SELECT GLOBAL PLAYERS 7. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 116 (including Divisions/Subsidiaries 124)
- The United States (75)
- Canada (5)
- Japan (2)
- Europe (37)
- France (4)
- Germany (7)
- The United Kingdom (10)
- Rest of Europe (16)
- Asia-Pacific (Excluding Japan) (5)
For more information about this report visit https://www.researchandmarkets.com/research/j...lobal?w=12
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Immune Disorders Drugs
